Crinetics Pharmaceuticals Inc CRN04777 Phase 1 Program Results Call Transcript - Thomson StreetEvents

Crinetics Pharmaceuticals Inc CRN04777 Phase 1 Program Results Call Transcript

Crinetics Pharmaceuticals Inc CRN04777 Phase 1 Program Results Call Transcript - Thomson StreetEvents
Crinetics Pharmaceuticals Inc CRN04777 Phase 1 Program Results Call Transcript
Published Sep 15, 2021
Published Sep 15, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of CRNX.OQ conference call or presentation 15-Sep-21 8:30pm GMT

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Crinetics Pharmaceuticals Inc
Ticker
CRNX.OQ
Time
8:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Jessica Macomber Fye - JPMorgan Chase & Co, Research Division - Analyst : I've got 3, so I'm just going to rattle them off. And first, can you please describe the most common adverse events and whether there was any imbalance between the treated volunteers and the placebo arms? I know you mentioned they were mild to moderate, but was there any dose dependence that you saw? Second, going back to the food effect you mentioned: Is the data in the slides from dosing patients in a fasted state? And can you elaborate on the food effect's magnitude on the PK exposure you observed? And lastly, thinking about the development path beyond the MAD, how much dose ranging work would you want to do in patients ahead of a total trial? Or is that something you could wrap into a single Phase II/III pivotal?

Table Of Contents

Crinetics Pharmaceuticals Inc to Host Key Opinion Leader (KOL) Webinar Transcript – 2023-08-08 – US$ 54.00 – Edited Transcript of CRNX.OQ corporate analyst meeting</ 8-Aug-23 4:00pm GMT

Crinetics Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript – 2023-01-11 – US$ 54.00 – Edited Transcript of CRNX.OQ presentation 11-Jan-23 11:00pm GMT

Crinetics Pharmaceuticals Inc to Discuss CRN04894 Phase 1 Multiple-Ascending Dose Data Call Transcript – 2022-05-25 – US$ 54.00 – Edited Transcript of CRNX.OQ conference call or presentation 25-May-22 12:00pm GMT

Crinetics Pharmaceuticals Inc To Discuss Results From MAD Cohorts Of The Phase 1 Trial Of CRN04777 Corporate Call Transcript – 2022-03-30 – US$ 54.00 – Edited Transcript of CRNX.OQ conference call or presentation 30-Mar-22 8:30pm GMT

Crinetics Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript – 2022-01-12 – US$ 54.00 – Edited Transcript of CRNX.OQ presentation 12-Jan-22 9:30pm GMT

Crinetics Pharmaceuticals Inc Review CRN04894 Single Ascending Dose Results Call Transcript – 2021-08-10 – US$ 54.00 – Edited Transcript of CRNX.OQ conference call or presentation 10-Aug-21 8:30pm GMT

Crinetics Pharmaceuticals Inc Q4 2020 Earnings Call Transcript – 2021-03-30 – US$ 54.00 – Edited Transcript of CRNX.OQ earnings conference call or presentation 30-Mar-21 8:30pm GMT

Crinetics Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript – 2021-01-13 – US$ 54.00 – Edited Transcript of CRNX.OQ presentation 13-Jan-21 9:30pm GMT

Crinetics Pharmaceuticals, Inc. - Special Call Transcript – 2020-11-20 – US$ 54.00 – Edited Transcript of CRNX.OQ conference call or presentation 20-Nov-20 4:00pm GMT

Crinetics Pharmaceuticals Inc Review Of Phase 2 Paltusotine Results Call Transcript – 2020-10-26 – US$ 54.00 – Edited Transcript of CRNX.OQ conference call or presentation 26-Oct-20 12:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Crinetics Pharmaceuticals Inc CRN04777 Phase 1 Program Results Call Transcript" Sep 15, 2021. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Crinetics-Pharmaceuticals-Inc-CRN04777-Phase-1-Program-Results-Call-T14988582>
  
APA:
Thomson StreetEvents. (2021). Crinetics Pharmaceuticals Inc CRN04777 Phase 1 Program Results Call Transcript Sep 15, 2021. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Crinetics-Pharmaceuticals-Inc-CRN04777-Phase-1-Program-Results-Call-T14988582>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.